SNTG2-AS1

Across TCGA pan-cancer cohorts, SNTG2-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated SNTG2-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNTG2-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNTG2-AS1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and PAAD show a favorable association.

KIRC, UVM, and KIRP are the cancer types where SNTG2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.524	0.724	<.001	108	view →
UVM	DFS	Tertile	All	0.441	0.937	<.001	90	view →
KIRP	OS	Median	II,III,IV	0.390	0.669	.009	39	view →
SKCM	DFS	Median	II,III,IV	0.307	0.183	.009	25	view →
UCS	DFS	Tertile	IV	0.360	0.938	.024	24	view →
PAAD	DFS	Quartile	All	0.624	0.240	.001	23	view →
THYM	OS	Tertile	All	1.000	0.757	.008	22	view →
PRAD	DFS	Quartile	All	0.929	0.980	<.001	18	view →
KICH	DFS	Tertile	All	0.738	0.956	.011	10	view →
HNSC	OS	Median	III,IV	0.467	0.220	.009	9	view →
LIHC	DFS	Tertile	II,III,IV	0.542	0.250	.015	9	view →
GBM	OS	Quartile	All	0.218	0.325	.037	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

SNTG2-AS1–KIRC (DFS)

Open the KIRC breakdown →